This document covers key points on what sponsors should consider when they plan to transfer clinical trial subjects from sites in Ukraine to sites in Estonia.
You can find the guidance here.
Considerations for transferring clinical trial subjects from sites in Ukraine to sites in Estonia
01.04.2022 | 13:39
Gallery
Due to possible disruptions caused by the Russian invasion of Ukraine, Estonian State Agency of Medicines have compiled a guidance for sponsors on how to manage the conduct of clinical trials in this situation.
